Modern Living Home Expo draws over 60,000 visitors on last day
KUCHING (June 9): The Modern Living Home Expo attracted over 60,000 visitors on its final day yesterday.
According to organising committee chairman Nicholas Tiong, the three-day event at Metrocity Convention Centre here surpassed the turnout recorded at the previous expo held earlier in February at the Borneo Convention Centre Kuching.
'As of midday, we welcomed more than 60,000 visitors to the expo, exceeding the previous record of around 40,000. I am confident the number will continue to rise by this event, as many people tend to make their way to the venue during the final hours to take advantage of exclusive discounts from exhibitors,' he told reporters when met yesterday.
The exhibition featured 300 booths, showcasing the offerings of 80 companies from across Kuching. These included the latest electrical appliances, home care essentials, DIY tools, and a variety of modern furniture.
'We chose Metrocity due to its strategic location and ease of access for the public, which is one of the key reasons for the significant increase in visitor numbers compared to the previous venue,' said Tiong.
Meanwhile, Kuching North Datuk Bandar Dato Hilmy Othman, who visited the exhibition, expressed strong support for the organiser's initiative in hosting it.
'We truly welcome efforts such as this, as they help revitalise the local economy, especially in areas under DBKU's (Kuching North City Commission) administration,' he said, adding that DBKU would assist the organisers with any needs to facilitate similar events in the future.
'Following the post-Covid recovery, economic activities are beginning to thrive once again. We must continue to nurture economic opportunities that generate income for exhibitors and those indirectly involved in the local economic ecosystem.
'I have been informed that public response to this expo has been very encouraging, and I hope to see more such activities held here at MCCC, as they can generate greater business and employment opportunities for our community,' Hilmy said. exhibition lead Modern Living Home Expo Nicholas Tiong
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 hours ago
- The Star
Britain's manufacturing contraction eases in July but outlook remains weak
LONDON, Aug. 1 (Xinhua) -- Britain's manufacturing downturn showed signs of easing in July, with the seasonally adjusted Manufacturing Purchasing Managers' Index (PMI) rising to a six-month high of 48, according to data released by S&P Global on Friday. The July PMI was slightly higher than 47.7 in June, but the index has now signalled contraction for ten consecutive months. S&P Global noted that risks persist, including fragile domestic and overseas market conditions, subdued consumer confidence, and manufacturers' ongoing concerns about costs. Market conditions remained subdued in July as British manufacturers reported weak spending willingness and low confidence at home and abroad. Rob Dobson, director at S&P Global Market Intelligence, said although the UK manufacturing sector is starting to send some tentatively encouraging signals, there's no assured path back to strong growth. Domestic clients are unwilling to spend due to cost rises triggered by higher minimum wages and employer national insurance contributions, while export markets are being buffeted by geopolitical stresses as well as trade and tariff uncertainties. The data also showed that new export orders have decreased over the past three and a half years. Additionally, the sector faced a weak labor market in July. The company attributed this to a combination of weak demand, rising staff costs, and subdued market confidence. Job losses were recorded for the ninth month in a row, with the pace of reductions over the past six months ranking among the sharpest since 2020, when the country was hit by the COVID-19 pandemic.
New Straits Times
4 hours ago
- New Straits Times
Cross-border trade to thrive after high-level consultation
IT took bilateral summitry at the highest level to revive cross-border free-trade arrangement at the Tebedu-Entikong border crossing between Sarawak and West Kalimantan in Indonesia. This deal was one of the highlights of the 13th Malaysia-Indonesia Annual Consultation meeting between Prime Minister Datuk Seri Anwar Ibrahim and Indonesian President Prabowo Subianto in Jakarta this week. Also present were Sarawak Premier Tan Sri Abang Johari Openg and Sabah Chief Minister Datuk Seri Hajiji Mohd Noor. Sarawak had long sought to revive the free flow of goods since Indonesia unilaterally stopped it in 2016. Sarawak set up an inland port early in 2010 because it seemed to make good economic sense to transport goods from Kuching Port to West Kalimantan via the Tebedu inland port rather than all the way from Java. At its height in 2013, some RM700 million in goods were reported to be traded this way. Numerous Sarawak missions to Indonesia seeking to reinstate the free-trade arrangement since then had been fruitless. It, of course, hardly needs stressing that free trade benefits all who engage in it. It also makes geographic sense for transshipment of goods to and from West Kalimantan via Tebedu and Kuching. Naturally, it also needs to be acknowledged that West Kalimantan has similar aspirations to become a trade transshipment hub with the commissioning of a new deep sea port near Pontianak, the provincial capital. The new port will also be well-served by land adjoining it, which has been earmarked for the development of industries. It so happened that a trade delegation from Sarawak led by Deputy Premier Datuk Amar Awang Tengah Ali Hasan was in West Kalimantan and East Kalimantan, also this week. The main mission was, of course, to deepen the economic relationship not just with West Kalimantan bordering Sarawak but in East Kalimantan where the new Indonesian capital of Nusantara is being developed. Sarawak has already identified several joint-ventures in developing dams in Kalimantan and even major real estate developer Ibraco Bhd was scouting about for possible projects in Balikpapan, the major city adjoining Nusantara. Awang Tengah was reportedly also reviewing localities for setting up a Sarawak trade and tourism office in Pontianak. This comes on the heels of the revival of air connectivity between Kuching and Pontianak next month. There has been much clamour both in Sarawak and West Kalimantan for flights between the two cities to resume after they were stopped during the Covid-19 pandemic. People-to-people exchanges have come back strongly since as witnessed by the daily long queues at the Tebedu-Entikong main border crossing as well as other secondary border posts. All these positive developments must be sustained through regular high-level official exchanges, especially in showing to the Indonesian side that free trade and the free flow of people across our common border is not a zero-sum proposition benefiting only one side. What happened in Jakarta this week also shows that Sarawak and Sabah can and do benefit substantially from close state-federal ties and working in tandem to take the fullest advantage from similarly close Malaysia-Indonesia bilateral ties.
The Sun
7 hours ago
- The Sun
Pfizer, BioNTech lose UK appeal in Moderna patent case
LONDON: Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their Covid-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last year, the High Court ruled that one of Moderna's patents relating to the messenger RNA (mRNA) technology which underpinned its Covid-19 vaccine was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to sales after March 2022. The High Court also ruled that the other Moderna patent under challenge in the case was invalid. Moderna was refused permission to appeal against that decision. But Pfizer and BioNTech were granted permission to appeal in an attempt to try and invalidate Moderna's second patent and appealed earlier this month, arguing Moderna's developments of mRNA technology were obvious developments of previous work, rendering the patent invalid. Judge Richard Arnold, however, rejected Pfizer and BioNTech's appeal. Pfizer and BioNTech said in a joint statement that the decision 'does not change our unwavering stance that this patent is invalid' and the companies will seek to appeal. 'This decision has no immediate impact on Pfizer and BioNTech or Comirnaty,' the companies added. Moderna did not immediately respond to a request for comment. Friday's decision in the latest ruling in the legal dispute between the two sides over their competing vaccines, which helped save millions of lives during the pandemic. The companies have also been involved in proceedings in Germany – where a court ruled in Moderna's favour in March – the United States Patent Office, which held that two Moderna Covid-19 vaccine patents were invalid, and elsewhere. - Reuters
